Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Deloitte

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,972,591

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,972,591
Title:Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions
Abstract: The present invention provides polypeptides including MCP1 fused, optionally, by a linker, to an immunoglobulin. Methods for using the polypeptides to treat medical disorders are also covered.
Inventor(s): Chou; Chuan-Chu (Westfield, NJ), Bober; Loretta A. (Linden, NJ), Sullivan; Lee (Somerset, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:12/621,228
Patent Claims:see list of patent claims

Details for Patent 7,972,591

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX Orphan search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2025-08-12 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Julphar
Covington
Baxter
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.